Dimezeft 500 Injection containing Ceftazidime is used for the management of a wide range of bacterial infections affecting various body systems. It helps control susceptible bacterial pathogens and supports effective infection management.
Ceftazidime works as a third-generation cephalosporin antibiotic by inhibiting bacterial cell wall synthesis, helping eliminate susceptible bacteria responsible for respiratory tract, urinary tract, skin, soft tissue, abdominal, and systemic infections.
The injection is widely prescribed in hospitals, intensive care units, and general medical practice for the treatment of moderate to severe bacterial infections requiring parenteral antibiotic therapy, leading to consistent prescription demand.
With the increasing prevalence of infectious diseases and growing demand for effective antimicrobial therapies, this product offers strong business potential for retailers and distributors. Its established clinical efficacy, broad-spectrum antibacterial coverage, and steady market demand make it a reliable product for growth in the anti-infective segment.